Velan Capital Investment Management LP
50 holdingsFiling period: 2026-06-30Current AUM: $125.8Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | PRAX | PRAXIS PRECISION MEDICINES I | 88.8K | $29.7M | $27.8M | 22.09% | -12,000 | 2026-06-30 |
| 2 | MPLT | MAPLIGHT THERAPEUTICS INC | 492.9K | $17.7M | $6.0M | 4.73% | -- | 2026-06-30 |
| 3 | STRO | SUTRO BIOPHARMA INC | 512.2K | $17.0M | $8.5M | 6.74% | -- | 2026-06-30 |
| 4 | IMMX | IMMIX BIOPHARMA INC | 1.08M | $11.2M | $13.2M | 10.47% | +345.0K | 2026-06-30 |
| 5 | TARA | PROTARA THERAPEUTICS INC | 2.84M | $10.9M | $10.7M | 8.48% | +10.0K | 2026-06-30 |
| 6 | TENX | TENAX THERAPEUTICS INC | 618.7K | $9.0M | $1.1M | 0.90% | +35.4K | 2026-06-30 |
| 7 | ABVX | ABIVAX SA | 65.6K | $8.7M | $7.0M | 5.57% | -11,370 | 2026-06-30 |
| 8 | AVR | ANTERIS TECHNOLOGIES GLOBAL | 700.0K | $6.9M | $5.8M | 4.64% | -- | 2026-06-30 |
| 9 | EDSA | EDESA BIOTECH INC | 827.5K | $6.7M | $3.4M | 2.71% | -- | 2026-06-30 |
| 10 | EVMN | EVOMMUNE INC | 451.3K | $6.0M | $4.5M | 3.58% | +5.0K | 2026-06-30 |
| 11 | AVTX | AVALO THERAPEUTICS INC | 324.5K | $6.0M | $5.2M | 4.15% | +139.3K | 2026-06-30 |
| 12 | XNCR | XENCOR INC | 255.0K | $4.1M | $6.1M | 4.81% | +5.0K | 2026-06-30 |
| 13 | RZLT | REZOLUTE INC | 750.0K | $3.9M | $3.1M | 2.47% | -- | 2026-06-30 |
| 14 | HRTX | HERON THERAPEUTICS INC | 8.75M | $3.7M | $2.7M | 2.18% | -- | 2026-06-30 |
| 15 | VRCA | VERRICA PHARMACEUTICALS INC | 471.6K | $2.9M | $2.2M | 1.72% | -- | 2026-06-30 |
| 16 | CCCC | C4 THERAPEUTICS INC | 570.0K | $2.7M | $2.0M | 1.55% | -- | 2026-06-30 |
| 17 | EPRX | EUPRAXIA PHARMACEUTICALS INC | 352.0K | $2.3M | $2.9M | 2.27% | -- | 2026-06-30 |
| 18 | ADMA | ADMA BIOLOGICS INC | 250.0K | $2.1M | $2.2M | 1.71% | -- | 2026-06-30 |
| 19 | RNTX | REIN THERAPEUTICS INC | 1.70M | $1.8M | $1.2M | 0.96% | -- | 2026-06-30 |
| 20 | LYEL | LYELL IMMUNOPHARMA INC | 105.0K | $1.5M | $1.1M | 0.91% | +3.0K | 2026-06-30 |
| 21 | — | NASUS PHARMA LTD | 359.4K | $1.3M | $1.3M | 1.00% | -- | 2026-06-30 |
| 22 | PROF | PROFOUND MED CORP | 170.3K | $1.1M | $967K | 0.77% | -115,432 | 2026-06-30 |
| 23 | JSPR | JASPER THERAPEUTICS INC | 2.67M | $1.1M | $1.5M | 1.21% | -- | 2026-06-30 |
| 24 | PTGX | PROTAGONIST THERAPEUTICS INC | 3.7K | $453K | $530K | 0.42% | -- | 2026-06-30 |
| 25 | CTMX | CYTOMX THERAPEUTICS INC. | 120.0K | $450K | $323K | 0.26% | -420,000 | 2026-06-30 |
← Scroll →
Page 1 of 2